Israel Englander Medpace Holdings, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $1.6 Million - $2.29 Million	5,000 Added 92.59%	10,400 $3.47 Million
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $2.01 Million - $2.29 Million	5,400 New	5,400 $2.22 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $4.55 Million - $6.25 Million	-20,000 Reduced 66.67%	10,000 $3.07 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $5.62 Million - $7.21 Million	30,000 New	30,000 $7.21 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $1.89 Million - $2.37 Million	13,000 Added 650.0%	15,000 $2.36 Million

618

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.